142 related articles for article (PubMed ID: 28608357)
21. Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia.
Rangi PS; Partridge WJ; Newlands ES; Waldman AD
Neuroradiology; 2005 Aug; 47(8):586-90. PubMed ID: 15997391
[TBL] [Abstract][Full Text] [Related]
22. Haemolytic uraemic syndrome after gemcitabine treatment for pancreatic carcinoma.
Choi M; Woywodt A; Göbel U; Schneider W; Kettritz R
Nephrol Dial Transplant; 1999 Oct; 14(10):2523-4. PubMed ID: 10528696
[No Abstract] [Full Text] [Related]
23. Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease.
Baron D; Mayo A; Kluger Y
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):90-1. PubMed ID: 16477934
[No Abstract] [Full Text] [Related]
24. [A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer].
Wato M; Inaba T; Ishikawa H; Ishikawa S; Baba N; Miyoshi M; Senoh T; Nagano T; Takaguchi K; Watanabe S; Kawai K
Nihon Shokakibyo Gakkai Zasshi; 2010 Oct; 107(10):1676-85. PubMed ID: 20938119
[TBL] [Abstract][Full Text] [Related]
25. Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine.
Burstein HJ
J Clin Oncol; 2000 Feb; 18(3):693-4. PubMed ID: 10653885
[No Abstract] [Full Text] [Related]
26. Cure of gemcitabine-induced systemic capillary leak syndrome without corticosteroids.
Spanos S; Vourliotaki I; Drossitis I; Tsoussis S
J BUON; 2009; 14(4):728-9. PubMed ID: 20148474
[No Abstract] [Full Text] [Related]
27. Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.
How J; Blattner M; Fowler S; Wang-Gillam A; Schindler SE
Neurologist; 2016 Nov; 21(6):112-117. PubMed ID: 27801773
[TBL] [Abstract][Full Text] [Related]
28. Gemcitabine-induced hemolytic uremic syndrome: a case report.
Brodowicz T; Breiteneder S; Wiltschke C; Zielinski CC
J Natl Cancer Inst; 1997 Dec; 89(24):1895-6. PubMed ID: 9414181
[No Abstract] [Full Text] [Related]
29. Gemcitabine-induced pseudocellulitis.
Caplan A; Chu DH; Rosenbach M; Svoboda J
Cutis; 2018 Nov; 102(5):E20-E23. PubMed ID: 30566560
[No Abstract] [Full Text] [Related]
30. Livedo racemosa and hemolytic uremic syndrome induced by gemcitabine.
Tognetti L; Garosi G; Rongioletti F; Fimiani M; Rubegni P
Int J Dermatol; 2016 Oct; 55(10):e555-6. PubMed ID: 27125732
[No Abstract] [Full Text] [Related]
31. [Is the frequency of hemolytic uremic syndrome as a complication of gemcitabine underestimated? The role of systematic screening].
Desramé J; Duvic C; Béchade D; Bredin C; Raynaud JJ; Defuentes G; Dourthe LM; Algayres JP
Gastroenterol Clin Biol; 2006 Feb; 30(2):332-4. PubMed ID: 16565677
[No Abstract] [Full Text] [Related]
32. Favorable outcome of gemcitabine-induced respiratory distress syndrome.
Girard T; Mouthon L; Boaziz C; Andre MH; Guillevin L
Ann Med Interne (Paris); 2000 Jun; 151(4):306-8. PubMed ID: 10922960
[TBL] [Abstract][Full Text] [Related]
33. [Inflammation of multiple seborrheic keratoses induced by chemotherapy with gemcitabine].
Siqueira CR; Miot HA
An Bras Dermatol; 2009; 84(4):410-3. PubMed ID: 19851675
[TBL] [Abstract][Full Text] [Related]
34. Sonography and CT of vasculitis during gemcitabine therapy.
Bendix N; Glodny B; Bernathova M; Bodner G
AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S14-5. PubMed ID: 15728007
[No Abstract] [Full Text] [Related]
35. [Severe interstitial pneumonitis related to Gemcitabine].
Sabria-Trias J; Bonnaud F; Sioniac M
Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
[TBL] [Abstract][Full Text] [Related]
36. Acute liver failure secondary to gemcitabine.
Stellman A; Loke MM; Mann S
BMJ Case Rep; 2010 Apr; 2010():. PubMed ID: 22736319
[TBL] [Abstract][Full Text] [Related]
37. [Gemcitabine: Applications and perspectives].
Tumori; 1997; 83(5):877-80. PubMed ID: 9446252
[No Abstract] [Full Text] [Related]
38. Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.
Mermershtain W; Cohen AD; Lazarev I; Grunwald M; Ariad S
J Chemother; 2003 Oct; 15(5):510-1. PubMed ID: 14598945
[TBL] [Abstract][Full Text] [Related]
39. Gemcitabine-induced thrombotic microangiopathy: a systematic review.
Izzedine H; Isnard-Bagnis C; Launay-Vacher V; Mercadal L; Tostivint I; Rixe O; Brocheriou I; Bourry E; Karie S; Saeb S; Casimir N; Billemont B; Deray G
Nephrol Dial Transplant; 2006 Nov; 21(11):3038-45. PubMed ID: 16968717
[No Abstract] [Full Text] [Related]
40. Targetoid erythema surrounding multiple seborrheic keratoses induced by chemotherapy with gemcitabine.
Retrosi C; Vezzoni R; Conforti C; Corneli P; Magaton-Rizzi G; Zalaudek I; Di Meo N
Acta Dermatovenerol Alp Pannonica Adriat; 2019 Dec; 28(4):185-186. PubMed ID: 31855275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
